A pooled analysis across SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM confirmed that semaglutide consistently reduces the composite of cardiovascular death or worsening heart failure events in this population
The American Diabetes Association Standards of Care emphasizes the importance of monitoring both efficacy and tolerability of GLP-1 therapies, with follow-up frequency individualized based on the specific medication, titration schedule, and patient response
Within the past two years, GLP-1 agonists, such as semaglutide and tirzepatide, have emerged as effective treatments in the fight against obesity and weight loss resistance
At the same time, its antioxidant properties also help to protect the skin from UV rays and environmental pollution
You may also see improvements in lipid profiles and, in people with fatty liver disease, liver function tests may improve with weight loss